Alife Health Aims To Improve IVF Outcomes With $9.5M Seed
Summary
Lux Capital led the seed round and was joined by Amplo, IA Ventures and Springbank Collective as well as a group of angel investors that include Anne Wojcicki, Fred Moll and Amira Yahyaoui. San Francisco-based Alife Health was founded in 2020 and is leveraging artificial intelligence and data to create personalized treatment insights so clinicians can make better decisions that maximize a patient’s chances of success while also lowering costs and barriers to IVF access. We aim to improve success rates across every cycle and bring costs down.” Before Alife Health, Maeder-York was building surgical robots to fight lung cancer and decided to go back to school to study how AI and machine learning was impacting medicine. The company has 11 full-time employees, and Maeder-York plans to double that by the end of the year in order to scale up to a full ecosystem of platforms that will integrate The next phase is getting the technology through regulatory submissions and out to patients. In addition, Alife is bringing equity and diversity into the fertility space that traditionally skewed to middle- and upper-class white families, she said in an interview.